Results 121 to 130 of about 1,690 (152)
Some of the next articles are maybe not open access.

Efficacy and safety of lomitapide in familial chylomicronaemia syndrome

Atherosclerosis, 2022
Gabriella Iannuzzo   +2 more
exaly  

Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study

European Journal of Preventive Cardiology, 2022
Tiziana Montalcini   +2 more
exaly  

Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia

Current Atherosclerosis Reports, 2020
Claudia Stefanutti, Stefanutti Claudia
exaly  

Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide

Current Medicinal Chemistry, 2020
Antonina Giammanco   +2 more
exaly  

Real-world safety and effectiveness of lomitapide in homozygous familial hypercholesterolaemia over ten years: Data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)

Atherosclerosis Plus
J. Cegla   +9 more
semanticscholar   +1 more source

Lomitapide affects HDL composition and function

Atherosclerosis, 2016
Elda Favari, L Calabresi, F Zimetti
exaly  

Home - About - Disclaimer - Privacy